[Federal Register Volume 73, Number 74 (Wednesday, April 16, 2008)]
[Notices]
[Pages 20718-20719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-8176]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 18, 2008, Aldrich 
Chemical Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 
45342-4304, made application by renewal to the Drug Enforcement 
Administration (DEA) as a bulk manufacturer of the basic classes of 
controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
N-Ethylamphetamine (1475)........................  I

[[Page 20719]]

 
N,N-Dimethylamphetamine (1480)...................  I
Aminorex (1585)..................................  I
Gamma Hydroxybutyric Acid (2010).................  I
Methaqualone (2565)..............................  I
Ibogaine (7260)..................................  I
Lysergic acid diethylamide (7315)................  I
Tetrahydrocannabinols (7370).....................  I
Mescaline (7381).................................  I
2,5-Dimethoxyamphetamine (7396)..................  I
3,4-Methylenedioxyamphetamine (7400).............  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
4-Methoxyamphetamine (7411)......................  I
Psilocybin (7437)................................  I
Psilocyn (7438)..................................  I
N-Ethyl-1-phenylcyclohexylamine (7455)...........  I
Dihydromorphine (9145)...........................  I
Normorphine (9313)...............................  I
Acetylmethadol (9601)............................  I
Alphacetylmethadol except levo-alphacetylmethadol  I
 (9603).
Normethadone (9635)..............................  I
Norpipanone (9636)...............................  I
3-Methylfentanyl (9813)..........................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Methylphenidate (1724)...........................  II
Amobarbital (2125)...............................  II
Pentobarbital (2270).............................  II
Secobarbital (2315)..............................  II
1-Phenylcyclohexylamine (7460)...................  II
Phencyclidine (7471).............................  II
Phenylacetone (8501).............................  II
1-Piperidinocyclohexanecarbonitrile (8603).......  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Dihydrocodeine (9120)............................  II
Oxycodone (9143).................................  II
Hydromorphone (9150).............................  II
Benzoylecgonine (9180)...........................  II
Ethylmorphine (9190).............................  II
Hydrocodone (9193)...............................  II
Isomethadone (9226)..............................  II
Meperidine (9230)................................  II
Meperidine Intermediate--A (9232)................  II
Meperidine Intermediate--B (9233)................  II
Methadone (9250).................................  II
Methadone Intermediate (9254)....................  II
Dextropropoxyphene, bulk, (non-dosage forms)       II
 (9273).
Morphine (9300)..................................  II
Thebaine (9333)..................................  II
Levo-alphacetylmethadol (9648)...................  II
Oxymorphone (9652)...............................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to produce isotope labeled standards for drug 
testing and analysis.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 16, 2008.

    Dated: April 9, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-8176 Filed 4-15-08; 8:45 am]
BILLING CODE 4410-09-P